Ask The Experts
Related Searches:
March 6, 2013
How will CMOs deal with new regulations to limit the strength of prescription acetominophen?
Read More »
March 6, 2013
How do I assess and convey the value of a novel protein expression system?
Read More »
March 6, 2013
What are the common biocompatibility tests that drug companies must perform during new drug development?
Read More »
January 22, 2013
What are the top concerns when choosing a clinical trial site in developed or emerging markets, and do cheaper prices in emerging markets outweigh those concerns?
Read More »
Gil Roth
October 26, 2012
Cold Chain is becoming more prevalent in clinical trials. What measures can we take to prevent deviations?
Read More »
October 5, 2012
What level of GMP need to be followed for clinical trial materials (for a generic ANDA) intended for animal studies if the drug is already in the market?
Read More »
October 5, 2012
Do you agree that the trend within clinical trials is moving towards using controlled ambient containers for regular room temperature shipments?
Read More »
October 5, 2012
What is the current industry average (in percentage) of API and formulation outsourcing in emerging markets?
Read More »
October 5, 2012
What homework will you do to try to assess the cost of a new outsourcing project?
Read More »
